J F Tomee

1.5k total citations
17 papers, 1.2k citations indexed

About

J F Tomee is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, J F Tomee has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in J F Tomee's work include Antifungal resistance and susceptibility (8 papers), Peptidase Inhibition and Analysis (5 papers) and Asthma and respiratory diseases (4 papers). J F Tomee is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Peptidase Inhibition and Analysis (5 papers) and Asthma and respiratory diseases (4 papers). J F Tomee collaborates with scholars based in Netherlands, United States and Germany. J F Tomee's co-authors include H. F. Kauffman, Henk F. Kauffman, Pieter S. Hiemstra, Peter Borger, G H Koëter, Albertus T.J. Wierenga, Regina Heinzel‐Wieland, P.S. Hiemstra, Tjip S. van der Werf and Jan G.R. de Monchy and has published in prestigious journals such as Annals of Internal Medicine, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

J F Tomee

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J F Tomee Netherlands 13 469 402 335 318 216 17 1.2k
M. Scot Roberts United States 19 344 0.7× 389 1.0× 314 0.9× 204 0.6× 353 1.6× 42 1.6k
P.T. Kimmitt United Kingdom 10 781 1.7× 288 0.7× 304 0.9× 306 1.0× 454 2.1× 19 1.4k
Susan Yost United States 10 288 0.6× 221 0.5× 173 0.5× 188 0.6× 342 1.6× 11 1.6k
A Caprón France 20 327 0.7× 219 0.5× 85 0.3× 135 0.4× 322 1.5× 52 1.5k
C R Hewitt United Kingdom 19 395 0.8× 81 0.2× 109 0.3× 419 1.3× 572 2.6× 35 1.3k
Lindsay A. Dent Australia 24 821 1.8× 199 0.5× 221 0.7× 231 0.7× 1.0k 4.7× 35 2.2k
Paul M. Fitch United Kingdom 18 170 0.4× 122 0.3× 191 0.6× 83 0.3× 348 1.6× 21 1.1k
Aruna K. Behera United States 20 198 0.4× 317 0.8× 269 0.8× 60 0.2× 351 1.6× 27 1.2k
Catharina Johansson Sweden 23 305 0.7× 111 0.3× 50 0.1× 588 1.8× 395 1.8× 46 1.6k
Azlinda Anwar United States 16 361 0.8× 164 0.4× 51 0.2× 171 0.5× 281 1.3× 22 1.0k

Countries citing papers authored by J F Tomee

Since Specialization
Citations

This map shows the geographic impact of J F Tomee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J F Tomee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J F Tomee more than expected).

Fields of papers citing papers by J F Tomee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J F Tomee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J F Tomee. The network helps show where J F Tomee may publish in the future.

Co-authorship network of co-authors of J F Tomee

This figure shows the co-authorship network connecting the top 25 collaborators of J F Tomee. A scholar is included among the top collaborators of J F Tomee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J F Tomee. J F Tomee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tomee, J F, et al.. (2008). Papillary carcinoma in struma ovarii: an unusual presentation.. PubMed. 66(6). 248–51. 6 indexed citations
2.
Kauffman, H. F. & J F Tomee. (2002). Defense Mechanisms of the Airways against Aspergillus fumigatus: Role in Invasive Aspergillosis. 94–113. 4 indexed citations
3.
Tomee, J F, et al.. (2000). Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. Journal of Allergy and Clinical Immunology. 105(6). 1185–1193. 277 indexed citations
4.
Borger, Pieter, et al.. (1999). Proteases fromAspergillus fumigatusInduce Interleukin (IL)–6 and IL‐8 Production in Airway Epithelial Cell Lines by Transcriptional Mechanisms. The Journal of Infectious Diseases. 180(4). 1267–1274. 120 indexed citations
5.
Tomee, J F, Ranny van Weissenbruch, Jan G.R. de Monchy, & Henk F. Kauffman. (1998). Interactions between inhalant allergen extracts and airway epithelial cells: Effect on cytokine production and cell detachment. Journal of Allergy and Clinical Immunology. 102(1). 75–85. 93 indexed citations
6.
Tomee, J F, G H Koëter, Pieter S. Hiemstra, & H. F. Kauffman. (1998). Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?. Thorax. 53(2). 114–116. 77 indexed citations
7.
Kauffman, Henk F. & J F Tomee. (1998). INFLAMMATORY CELLS AND AIRWAY DEFENSE AGAINST ASPERGILLUS FUMIGATUS. Immunology and Allergy Clinics of North America. 18(3). 619–640. 35 indexed citations
8.
Tomee, J F, Pieter S. Hiemstra, & Henk F. Kauffman. (1997). Proteases from Aspergillus induce release of pro-inflammatory cytokines and cell detachment in airway epithelial cell lines. Immunology Letters. 56. 186–186. 1 indexed citations
9.
Tomee, J F, P.S. Hiemstra, Regina Heinzel‐Wieland, & H. F. Kauffman. (1997). Antileukoprotease: An Endogenous Protein in the Innate Mucosal Defense against Fungi. The Journal of Infectious Diseases. 176(3). 740–747. 136 indexed citations
10.
Tomee, J F, Albertus T.J. Wierenga, Pieter S. Hiemstra, & Henk F. Kauffman. (1997). Proteases fromAspergillus fumigatusInduce Release of Proinflammatory Cytokines and Cell Detachment in Airway Epithelial Cell Lines. The Journal of Infectious Diseases. 176(1). 300–303. 160 indexed citations
11.
Tomee, J F, Pieter S. Hiemstra, Regina Heinzel‐Wieland, & Henk F. Kauffman. (1997). Antileukoprotease; An endogenous protein in the innate mucosal defense against fungi. Immunology Letters. 56. 179–179. 3 indexed citations
12.
Tomee, J F, A. E. J. Dubois, G H Koëter, et al.. (1996). Specific IgG4 Responses During Chronic and Transient Antigen Exposure in Aspergillosis. American Journal of Respiratory and Critical Care Medicine. 153(6). 1952–1957. 19 indexed citations
13.
Tomee, J F, et al.. (1996). Serodiagnosis and Monitoring of Aspergillus Infections after Lung Transplantation. Annals of Internal Medicine. 125(3). 197–201. 29 indexed citations
14.
Kauffman, H. F., et al.. (1995). Review of Fungus-Induced Asthmatic Reactions. American Journal of Respiratory and Critical Care Medicine. 151(6). 2109–2115. 109 indexed citations
15.
Tomee, J F, Tjip S. van der Werf, Jean‐Paul Latgé, et al.. (1995). Serologic Monitoring of Disease and Treatment in a Patient with Pulmonary Aspergilloma. American Journal of Respiratory and Critical Care Medicine. 151(1). 199–204. 38 indexed citations
17.
Tomee, J F, et al.. (1994). Immunologic significance of a collagen-derived culture filtrate containing proteolytic activity in -related diseases. Journal of Allergy and Clinical Immunology. 93(4). 768–778. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026